CCR2 and hepatocellular carcinoma: Bartneck’s study demonstrated that immunosuppressive TAMs are abundant in the center of HCC and that CCR2+ TAMs accumulate at the highly vascularized border of tumor; In vivo experiments showed that inflammatory and angiogenic pathways are activated in CCR2+ TAMs (57).